S. UYTUN Et Al. , "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?," ERS Congress 2022 , Barselona, Spain, 2022
UYTUN, S. Et Al. 2022. One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?. ERS Congress 2022 , (Barselona, Spain).
UYTUN, S., Eryımaz polat, S., ÖZKAN TABAKÇI, S., CİNEL, G., EMİRALİOĞLU, N., YALÇIN, E. E., ... KİPER, E. N.(2022). One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses? . ERS Congress 2022, Barselona, Spain
UYTUN, SALİH Et Al. "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?," ERS Congress 2022, Barselona, Spain, 2022
UYTUN, SALİH Et Al. "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?." ERS Congress 2022 , Barselona, Spain, 2022
UYTUN, S. Et Al. (2022) . "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?." ERS Congress 2022 , Barselona, Spain.
@conferencepaper{conferencepaper, author={SALİH UYTUN Et Al. }, title={One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?}, congress name={ERS Congress 2022}, city={Barselona}, country={Spain}, year={2022}}